Cline Christopher R. bought TVTX
December 1, 2025 · Form 4 insider transaction
Cline Christopher R. bought 20,000 shares of Travere Therapeutics, Inc. at $16.23 per share, a transaction worth $324.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$16.23
Total value
$324.6K
InsiderCline Christopher R.
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 1, 2025
Filing dateDecember 3, 2025
Shares owned after112,083
OwnershipDirect
10b5-1 planNo
AmendedNo